EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation

Mashiat Zaman iD, Govinda Sharma, Walaa Almutawa, Tyler Gb Soule iD, Rasha Sabouny iD, Matt Joel, Armaan Mohan iD, Cole Chute, Jeffrey T Joseph, Gerald Pfeffer iD, Timothy E Shutt iD

Life Science Alliance · 2025-06 · 8 (6) · e202402921

DOI: 10.26508/lsa.202402921 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Life Science Alliance, online erschienen am 02.04.2025. Verfasst von Mashiat Zaman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada. Hauptthemen laut MEDLINE: DNA, Mitochondrial, GTP Phosphohydrolases, Inflammation, Mitochondrial Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U of C | Alberta Children's Hospital Research Institute, Canadian Government | Canadian Institutes of Health Research, New Frontiers Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in the mitochondrial protein MFN2 are typically associated with a peripheral neuropathy phenotype, but can also cause a variety of additional pathologies including myopathy. Here, we identified an uncharacterized MFN2 variant, Q367H, in a patient diagnosed with late-onset distal myopathy, but without peripheral neuropathy. Supporting the hypothesis that this variant contributes to the patient’s pathology, patient fibroblasts and transdifferentiated myoblasts showed changes consistent with impairment of several MFN2 functions. We also observed mtDNA outside of the mitochondrial network that colocalized with early endosomes, and measured activation of both TLR9 and cGAS-STING inflammation pathways that sense mtDNA. Re-expressing the Q367H variant in MFN2 KO cells also induced mtDNA release, demonstrating this phenotype is a direct result of the variant. As elevated inflammation can cause myopathy, our findings linking the Q367H MFN2 variant with elevated TLR9 and cGAS-STING signalling can explain the patient’s myopathy. Thus, we characterize a novel MFN2 variant in a patient with an atypical presentation that separates peripheral neuropathy and myopathy phenotypes, and establish a potential pathomechanism connecting MFN2 dysfunction to mtDNA-mediated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialGTP PhosphohydrolasesInflammationMitochondrial ProteinsHumansFibroblastsMembrane ProteinsMitochondriaMutationNucleotidyltransferasesPeripheral Nervous System DiseasesPhenotypeSignal TransductionToll-Like Receptor 9Cyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING Protein

Substanzen

DNA, MitochondrialGTP PhosphohydrolasesMembrane ProteinsMitochondrial ProteinsNucleotidyltransferasesToll-Like Receptor 9cGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseMFN2 protein, humanSTING1 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Department of Neuroscience, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Hotchkiss Brain Institute, Department of Clinical Neurosciences, Department of Pathology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Hotchkiss Brain Institute, Department of Clinical Neurosciences; and Alberta Child Health Research Institute, Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Canada gerald.pfe…
  • Departments of Medical Genetics and Biochemistry & Molecular Biology, Cumming School of Medicine, Hotchkiss Brain Institute, Snyder Institute for Chronic Diseases, Alberta Children's Hospital Research Institute; Univers…

ORCID-Profile: Mashiat Zaman, Tyler Gb Soule, Rasha Sabouny, Armaan Mohan, Gerald Pfeffer, Timothy E Shutt

Förderung

  • U of C | Alberta Children's Hospital Research Institute
  • Canadian Government | Canadian Institutes of Health Research
  • New Frontiers Research Fund
  • Hotchkiss Brain Institute, University of Calgary
  • Canada Foundation for Innovation
  • Neuromuscular Genetics

Zitieren

APA

Zaman, M., Sharma, G., Almutawa, W., Soule, T. G., Sabouny, R., Joel, M., Mohan, A., Chute, C., Joseph, J. T., Pfeffer, G., & Shutt, T. E. (2025). The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation. Life Science Alliance, 8(6), e202402921. https://doi.org/10.26508/lsa.202402921

Vancouver

Zaman M, Sharma G, Almutawa W, Soule TG, Sabouny R, Joel M, et al. The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation. Life Science Alliance. 2025;8(6):e202402921. doi:10.26508/lsa.202402921

BibTeX
@article{Zaman2025,
  author = {Zaman, Mashiat and Sharma, Govinda and Almutawa, Walaa and Soule, Tyler Gb and Sabouny, Rasha and Joel, Matt and Mohan, Armaan and Chute, Cole and Joseph, Jeffrey T and Pfeffer, Gerald and Shutt, Timothy E},
  title = {The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation},
  journal = {Life Science Alliance},
  year = {2025},
  volume = {8},
  number = {6},
  pages = {e202402921},
  doi = {10.26508/lsa.202402921}
}
Kostenlos starten →